TAIWO GBADEBO: Open Payments
NPI 1700201241 · VOORHEES, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,686 in 98 payments from 15 companies in 2025. Trend: 2023 $39 · 2024 $556 · 2025 $1,686
Food & beverage: $1,686
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $577 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $167 |
| Lilly USA, LLC | 7 | $141 |
| Regeneron Healthcare Solutions, Inc. | 5 | $97 |
| Madrigal Pharmaceuticals | 5 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $90 |
| Phathom Pharmaceuticals, Inc. | 6 | $85 |
| Celltrion USA Inc. | 5 | $85 |
| PFIZER INC. | 5 | $84 |
| Ardelyx, Inc. | 4 | $80 |
Products named: RINVOQ, XIFAXAN, OMVOH, DUPIXENT, SKYRIZI, REZDIFFRA, ENTYVIO, CREON.
Industry payments across NJ — which companies pay providers there.
